Trial Outcomes & Findings for Evaluation of Respiratory Heast Loss as a Physiologic Patient Monitor for Acute Care Medicine (NCT NCT01808963)
NCT ID: NCT01808963
Last Updated: 2017-05-30
Results Overview
Respired gas heat content
Recruitment status
COMPLETED
Target enrollment
13 participants
Primary outcome timeframe
1 year.
Results posted on
2017-05-30
Participant Flow
Recruitment from 12/19/12 through 5/31/13 in the UCDMC Peri-operative Suite.
Participant milestones
| Measure |
Study Group
Patients undergoing elective surgery requiring endotracheal intubation for anesthesia.
|
|---|---|
|
Overall Study
STARTED
|
13
|
|
Overall Study
COMPLETED
|
13
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Evaluation of Respiratory Heast Loss as a Physiologic Patient Monitor for Acute Care Medicine
Baseline characteristics by cohort
| Measure |
Study Group
n=13 Participants
Respiratory Heat Loss Measured in Joules Per Minute
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
11 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
2 Participants
n=5 Participants
|
|
Age, Continuous
|
50 years
STANDARD_DEVIATION 14.3 • n=5 Participants
|
|
Sex: Female, Male
Female
|
8 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
5 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
13 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 1 year.Respired gas heat content
Outcome measures
| Measure |
Study Group
n=13 Participants
Joules per minute
|
|---|---|
|
Evaluation of Respiratory Heat Loss as a Physiologic Patient Monitor for Acute Care Medicine
|
29.7 Joules per minute
Standard Deviation 15.6
|
Adverse Events
Study Group
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place